We develop, manufacture, license, and market point-of-care diagnostic tests and technology for the detection of infectious diseases and other conditions.
About Chembio Diagnostics:
Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, including COVID-19, sexually transmitted disease, and fever and tropical disease. Coupled with Chembio’s extensive scientific expertise, its novel DPP® technology offers broad market applications beyond infectious disease. Chembio’s products are sold globally,
Operating as usual
There is a new Subvariant, BA.2.12.1, spreading rapidly in the US. Cases have increased over 50% in the last 2 weeks. All but 1 State is seeing an increase in the number of cases.
This new variant is more contagious than the previous variants, and the Biden administration is predicting over 100M infections for the coming fall and winter season.
It is important to prepare for a potential surge in cases. Learn more about Chembio's available COVID POC tests: https://hubs.ly/Q019XFVP0
April is STD Awareness Month, and the CDC has released the most recent data on STDs from 2020
Syphilis has increased by 52% since 2016, and Congenital Syphilis has increased 235% since 2016. More than half of the reported cases of STDs were between the ages of 15-24.
The CDC puts a large emphasis on testing for STDs to help prevent the spread.
Learn more about Chembio's HIV-Syphilis combo test: https://hubs.ly/Q0194FRD0
A subvariant of Omicron has emerged. This variant is thought to be more contagious than the original Omicron Variant.
Ba.2 subvariant has been rapidly spreading throughout the US and is now accounting for 72% of new COVID cases, according to the CDC.
Testing is still an important part of keeping our loved ones and communities safe.
Learn more about our COVID tests: https://hubs.ly/Q018RkWK0
UNITAID has announced groundbreaking development; PrEP injections have rolled out in Brazil and South Africa as an alternative to the daily PrEP pill! One injection can offer up to 2 months of protection.
This is the same PrEP injection that was FDA approved in late December of 2021 in the US.
FDA Requires HIV testing prior to prescribing PrEP. Learn more about Chembio's POC HIV tests: https://hubs.ly/Q018RhcF0
A study done by the University of Oxford has found a new variant of HIV. This new variant has shown to be potentially more infectious, and weaken the immune system much faster than previous HIV strains.
It is crucial that we continue to test high risk populations, as early intervention is key in helping to treat this new variant.
Chembio supplies a variety of Rapid HIV testing solutions. Learn more about our products: https://hubs.ly/Q015mCyK0
The FDA has expanded the medical device shortage list to include all blood specimen collection tubes. This shortage is affecting the availability of STD testing, specifically for HIV and Syphilis.
The FDA recommended any Organizations experiencing supply issues consider POC lateral flow testing, among other things.
Chembio, as a market leader, offers multiple HIV & HIV-Syphilis testing solutions.
Learn more: https://hubs.ly/Q014Fwkf0
National Black HIV/AIDS Awareness Day is February 7 and is a day to address the impact of HIV on Black communities. When we work to overcome structural barriers to HIV testing, prevention, and treatment, we can .
Chembio is dedicated to raising awareness around HIV, and providing reliable, efficient POC testing.
Learn more: https://hubs.ly/Q013grx20
Feb. 7 is National Black HIV/AIDS Awareness Day. Let’s celebrate progress in reducing new HIV diagnoses and recognize that to , we must address barriers like racism, homophobia, & transphobia.
Chembio is dedicated to raising awareness around HIV, and providing reliable, efficient POC testing.
Learn more here: https://hubs.ly/Q013gvW00
A new PrEP injection to prevent HIV has been approved by the FDA!
This injection is only needed once every 8 weeks, and can increase the use of PrEP for populations who find it hard to take a daily pill.
Taking PrEP and regular testing are the best ways to help stop the HIV Epidemic.
Chembio offers a variety of HIV testing solutions.
Learn more here: https://hubs.ly/Q011C_VV0
COVID and Flu cases are rapidly rising, and experts warn that we could be facing a "twindemic".
It is important to continue testing in an effort to stop and reduce the spread of both COVID and Flu.
Chembio provides rapid testing solutions for COVID and COVID/Flu
Learn more here: https://hubs.ly/Q011D0_R0
There has been an increase of 335% in Flu activity compared to last season, according to the Walgreens Flu Index.
There has been double the number of people that are getting tested for Flu compared to the 2019-2020 season
It is important now more than ever to make sure that we have the proper tools to differentiate between COVID-19 & Flu.
Chembio offers testing solutions, that in silico indicates, will detect the Omicron variant for Symptomatic and Asymptomatic patients, and multiplex COVID/Flu testing.
Learn more here: https://hubs.ly/Q010Xs3D0
COVID-19 Omicron Variant has been found in over 57 Countries around the world. The WHO has stated that this variant could "have a major impact on the course of the pandemic"
A preliminary study in South Africa found that the variant significantly reduced antibody protection
Chembio offers testing solutions, that in silico indicates, will detect the Omicron variant for Symptomatic and Asymptomatic patients, and multiplex COVID/Flu testing.
Learn more about our tests here: https://hubs.ly/Q010Xs6n0
As you may know, today is World AIDS Day! This years theme is “Ending the HIV Epidemic: Equitable Access, Everyone’s Voice”
Each year, organizations & individuals around the world raise attention to the HIV epidemic, to increase awareness, knowledge, speak out against HIV stigma, and call for an increased response in Ending the HIV Epidemic in the U.S.
Chembio is proud to provide fast, reliable HIV tests to those who need it the most
To learn more about our tests, visit: https://hubs.ly/H0_tBK-0
December 1st is World AIDS Day, and this year's theme is "Ending the HIV Epidemic: Equitable Access, Everyone's Voice"
Help spread awareness, knowledge, speak out against HIV stigma, and call for an increased response to move toward Ending the HIV Epidemic in the US.
Chembio is proud to offer a variety of tests for HIV.
To learn more about our tests, visit: https://hubs.ly/H0_tBsc0
There was recently an outbreak of Flu in the University of Michigan and the CDC plans to investigate how it is spreading.
There have also been reported outbreaks in other Universities, like Rowan University, Florida State University, and Florida A&M.
With a lot of Students going home for the holidays, this could significantly increase the spread of the Flu.
Chembio provides a Flu and COVID combination rapid test to differentiate Flu A&B, and COVID-19
Learn more here: https://hubs.ly/H0_tl7y0
The CDC has given the OK for children aged 5-11 to receive the COVID-19 vaccine. This is great progress in the face of the pandemic!
However, this does not mean that we should let our guard down. Testing is another great way to help stop the spread of COVID-19
Chembio provides several COVID & COVID/Flu testing devices
Learn more about our tests here: https://hubs.ly/H0-PMFl0
We are looking to hire 100+ positions!
Stop by the Chembio booth TOMORROW at the LGBT Job Fair at the LGBT Network Hauppauge Center on Oct. 27th from 10am-2pm!
Visit https://hubs.ly/H0Zvqfj0 Or call 631-924-1135 for more information
Looking to advance your career?
Stop by the Chembio booth at the LGBT Job Fair at the LGBT Network Hauppauge Center on Oct. 27th from 10am-2pm!
We are looking to hire 100+ positions!
Visit https://hubs.ly/H0Zv9cm0 Or call 631-924-1135 for more information
With the rising rates of COVID-19, and the upcoming flu season, it is important to ensure your staff and patients remain safe.
One way to ensure that is by testing!
Chembio offers a portfolio of testing solutions for COVID-19 & Flu.
Learn more about our tests here: https://hubs.ly/H0YR7bs0
JOIN US NOW!!
Join our Job Fair TODAY, Sept 22nd from 2pm-7pm at 3661 Horseblock Rd, Medford, NY 11763
Start your career with any of the several open positions listed below, and receive a $2000 Sign on Bonus!*
Walk-ins Welcome!
For more information call us at 631-924-1135
We are hiring now!!
Join our Job Fair this week, Sept 22nd from 2pm-7pm at 3661 Horseblock Rd, Medford, NY 11763
Start your career with any of the several open positions listed below, and receive a $2000 Sign on Bonus!*
Walk-ins Welcome!
For more information call us at 631-924-1135
Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $10 billion point-of-care testing market. Chembio's three FDA PMA-approved, CLIA-waived, rapid HIV tests include: SURE CHECK® HIV 1/2 Assay for blood, HIV 1/2 STAT-PAK® Assay for blood and DPP® HIV 1/2 Assay for blood or oral fluid. Chembio markets internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP®) technology, which has significant advantages over lateral-flow technologies. Our Next Generation DPP technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products. Headquartered in Medford, NY, with approximately 150 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U.S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485. For more information, please visit: www.chembio.com.
Monday | 8am - 5:30pm |
Tuesday | 8am - 5:30pm |
Wednesday | 8am - 5:30pm |
Thursday | 8am - 5:30pm |
Friday | 8:30am - 5:30pm |
Bactolac Pharmaceutical is an industry-leading private label vitamin manufacturer offering the highest quality nutritional supplements at the best prices.